Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What's up with nonoxynol-9?

A Forbes1, L Heise

  • 1aforbes@critpath.org

Reproductive Health Matters
|June 26, 2001
PubMed
Summary
This summary is machine-generated.

Advantage-S, a spermicide containing nonoxynol-9 (N-9), failed to protect women against HIV transmission in a clinical trial. Further research is crucial for developing effective topical microbicides.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Managing Blood Pressure in Dialysis Patients: A Summary of UK Clinical Practice Guideline.

Kidney international reports·2026
Same author

Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial.

Journal of viral hepatitis·2025
Same author

The performance of small sample correction methods for controlling type I error when analyzing parallel cluster randomized trials: a systematic review of simulation studies.

Journal of clinical epidemiology·2025
Same author

TIAMAT- towards an interdisciplinary automated malnutrition screening tool.

Clinical nutrition ESPEN·2025
Same author

Standardising and simplifying the Global Leadership Initiative on Malnutrition (GLIM) for its more general application.

Clinical nutrition ESPEN·2024
Same author

A vanguard randomised feasibility trial comparing three regimens of peri-operative oxygen therapy on recovery after major surgery.

Anaesthesia·2023

Area of Science:

  • Reproductive Health
  • Infectious Diseases
  • Clinical Trials

Background:

  • Nonoxynol-9 (N-9) has been used in spermicides, with some studies suggesting it could prevent sexually transmitted infections (STIs).
  • Recent trials have questioned the efficacy of N-9 products against both HIV and bacterial STDs.

Purpose of the Study:

  • To evaluate the efficacy of Advantage-S, a spermicide containing N-9, in preventing HIV transmission among women.
  • To assess the protective effects of N-9 against bacterial STDs.

Main Methods:

  • A randomized, controlled trial sponsored by UNAIDS involving female sex workers with high-risk sexual behavior.
  • Comparison of HIV incidence between women using Advantage-S and those using a vaginal lubricant.

Main Results:

Related Experiment Videos

  • Advantage-S did not protect women against sexual transmission of HIV.
  • The group using Advantage-S experienced a higher incidence of new HIV infections compared to the control group.
  • Recent studies indicate low-dose N-9 products do not protect against bacterial STDs like gonorrhea and chlamydia.

Conclusions:

  • Advantage-S is likely not an effective microbicide for HIV prevention.
  • The failure of Advantage-S highlights the urgent need for research and development of safe and effective topical microbicides.
  • Effective microbicides can still be developed, but Advantage-S is not a viable candidate.